Cellectar Biosciences, a Madison company working on cancer-fighting compounds, reported a net loss of $5.5 million, or $7.03 a share for the 2015 fiscal year, down from a net loss of $8.1 million, or $17.53 a share, for 2014. Read the full Wisconsin State Journal story here.
- WisBusiness: WARF, WiSys portfolios available for ‘browsing’ by tech, industry shoppersDecember 17, 2018
- WisBiz: The Show’ covers Tech Metrics, Tom Still commentary; interview with Mike PartschDecember 17, 2018
- InsideWis: The late Bill Kraus defined what it meant to be a citizen of WisconsinDecember 15, 2018
- WARF, WiSys portfolios available for ‘browsing’ by tech, industry shoppersDecember 14, 2018
- New forum aims to connect tech sector, healthcare providersDecember 13, 2018